1. P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE. (23rd June 2022) Authors: Innes, A.; Orovboni, V.; Claudiani, S.; Fernando, F.; Khan, A.; Byrne, J.; Gallipoli, P.; Copland, M.; Horne, G.; Arnold, C.; Collins, A.; Cunningham, N.; Danga, A.; Frewin, R.; Garland, P.; Hannah, G.; Hassan, S.; Makkuni, S.; Rothwell, K.; Foroni, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P713: REAL-WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML. (23rd June 2022) Authors: Nesr, G.; Szydlo, R.; Braithwaite, B.; Frackelton, S.; Mathew, P.; Hashmi, M.; Fernando, F.; Innes, A.; Claudiani, S.; Khan, A.; Rao, A.; Foroni, L.; Milojkovic, D.; Apperley, J. F.; Clark, R. E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗